34. Kongress der Deutschen Kontinenz Gesellschaft
Deutsche Kontinenz Gesellschaft e. V.
03.11. - 04.11.2023, Leipzig
OAB / NDO
Meeting Abstract
(27)
[Full Text]
Stellenwert der Urodynamik in der urologischen Versorgungsrealität
Baunacke M, Kontschak L, Grabbert M, Borkowetz A, Mehralivand S, Eisenmenger N, Huber J, Schultz-Lampel D[Full Text]
Meeting Abstract
(28)
[Full Text]
Ein neues Dokumentationsinstrument in der Neuro-Urologie – Hybrid für Forschung und Klinik
Jaekel AK, Kowollik M, Kutzenberger J, Böthig R, Kaufmann A, Kirschner-Hermanns R[Full Text]
Meeting Abstract
(29)
[Full Text]
Urologische Versorgungssituation von Patienten mit MS
Kaufmann A, Gedamke M, Leidl Q, Kirschner-Hermanns R[Full Text]
Meeting Abstract
(30)
[Full Text]
Comparison of adverse events (AE) of different treatments for neurogenic detrusor overactivity (NDO)
Gedamke M, Steffen Y, Leidl Q[Full Text]
Meeting Abstract
(31)
[Full Text]
Efficacy and safety data from real life treatment of first in Germany registered intravesical oxybutynin for patients with neurogenic detrusor overactivity (NDO)
Kalke YB, Ho HT, Leidl Q, Angermund A, Elishar R, Frech-Dörfler M, Hirsch A, Kirschner-Hermanns R, Tornic J, Queissert F, Rahnama'i S, Rehme C, Reitz A, Schindler O, Schmitz F, Schultz-Lampel D, Gedamke M[Full Text]
Meeting Abstract
(32)
[Full Text]
Streptozotocin-induced diabetes has no major effects on the role of sphingosine kinase and sphingosine 1 phosphate in rat bladder
Rakhmatova G, Bese Ö, Kucukyildiz K, Arioglu-Inan E, Michel M[Full Text]
